Back to Search Start Over

CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion.

Authors :
Llaó Cid, Laura
Hanna, Bola S.
Iskar, Murat
Roessner, Philipp M.
Öztürk, Selcen
Lichter, Peter
Zapatka, Marc
Seiffert, Martina
Source :
Leukemia & Lymphoma; Feb2020, Vol. 61 Issue 2, p351-356, 6p
Publication Year :
2020

Abstract

Chronic lymphocytic leukemia (CLL) is associated with an accumulation of oligoclonal CD8<superscript>+</superscript> effector T-cells, which control leukemia progression in mice, but gradually acquire a dysfunctional phenotype along with disease progression. Exhaustion of CD8<superscript>+</superscript> T-cells is characterized by increased expression of inhibitory receptors like PD-1, decreased proliferation, and reduced effector function such as cytokine production, which reduces anti-tumor control. Despite the accumulation of exhausted PD-1<superscript>+</superscript> CD8<superscript>+</superscript> T-cells in secondary lymphoid organs of CLL patients, immune checkpoint blockade as a means to reinvigorate anti-tumor T-cell activity has not shown the expected efficacy. This highlights the need for a better understanding of T-cell exhaustion in CLL. Here, we uncover the transcriptional program of T-cell exhaustion in CLL by comparing naïve with dysfunctional effector CD8<superscript>+</superscript> T-cells with high PD-1 expression from mice after adoptive transfer of Eµ-TCL1 leukemic cells. Our data provide clear evidence for activation-induced dysfunction of CD8<superscript>+</superscript> T-cells in the CLL microenvironment and assess the heterogeneity in the expression of functionally relevant proteins in specific clusters of CD8<superscript>+</superscript> T-cells at a single-cell level. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10428194
Volume :
61
Issue :
2
Database :
Complementary Index
Journal :
Leukemia & Lymphoma
Publication Type :
Academic Journal
Accession number :
141376952
Full Text :
https://doi.org/10.1080/10428194.2019.1660972